Evaluation of Group Lifestyle Balance DVD in Primary Care Practice (STEP UP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine different ways of delivering the Group Lifestyle Balance (GLB) intervention (1). The GLB is a 12-week lifestyle change program based on the highly successful lifestyle program that was used in the Diabetes Prevention Program (DPP)(2). A DVD of the Group Lifestyle Program has been developed. Conditions called metabolic syndrome and pre-diabetes increase the risk of diabetes and heart disease. Recent research has shown that type 2 diabetes and metabolic syndrome may be prevented or delayed by making lifestyle changes. Two local primary care practices will be randomly assigned to either the GLB-DVD intervention or usual care. Two additional practices will provide the GLB using trained preventionists for delivery. Approximately 15 patients will be recruited in each practice. It is not known if the GLB intervention works better than what is usually done at the present time for people with metabolic syndrome or pre-diabetes. It is hoped that this research study will provide information to help answer that question.
| Condition | Intervention |
|---|---|
|
Prediabetes Metabolic Syndrome |
Behavioral: Group Lifestyle Balance |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Screening, Training, Education and Prevention Service of the University of Pittsburgh, Phase 2 |
- The primary outcome for this study will be changes in weight measured pre and post intervention, as well as at the 6 and 12 month assessments. [ Time Frame: Baseline, 3, 6, and 12 months ] [ Designated as safety issue: No ]
- Key secondary outcomes for this study will include changes in glucose as well as global CVD risk. Quality of life and quality of well-being will also be assessed. [ Time Frame: Baseline, 3, 6 and 12 months ] [ Designated as safety issue: No ]
| Enrollment: | 23 |
| Study Start Date: | June 2007 |
| Study Completion Date: | May 2009 |
| Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
-
Behavioral: Group Lifestyle Balance
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
- All non-diabetic patients age 18 years and older at the time of enrollment considered to be patients of the practices that are taking part in this project will be eligible for the study upon referral from their physician.
Non-diabetic patients with metabolic syndrome AND/OR pre-diabetes are eligible for the study with referral from their physician based on the following criteria:
Metabolic Syndrome: Patients with BMI greater than or equal to 25 kg/m2, with at least 3 of the following risk factors for metabolic syndrome:
- Waist circumference (>40 inches men, >35 inches women)
- Blood pressure greater than or equal to 130 mmHg (systolic) and/or 85 mmHg (diastolic) OR history of diagnosed hypertension
- Low HDL level (<40mg/dL men, <50 mg/dL women)
- Elevated triglyceride level greater than or equal to 150 mg/dL
- Fasting glucose greater than or equal to 100mg/dL and <126mg/dL
- Pre-diabetes: Patients with a BMI greater than or equal to 25 kg/m2 and pre-diabetes (fasting glucose greater than or equal to 100 mg/dL and <126mg/dL)
- All measures should have been taken within six months of enrollment into the study. The physician in each center will be asked to refer eligible patients to the study. It will be the responsibility of the referring physician to determine eligibility and appropriateness of the patient's participation.
Exclusion Criteria:
Those patients age less than 18 years old will not be invited to be part of the study. In addition, patients with any of the following conditions are not eligible to take part in the study:
- Those with previous diabetes diagnosis
- Women who are currently (or within past 6-weeks) pregnant or lactating
- Any patient deemed by their physician not to be a candidate
- Any patient planning to leave the area before the end of the program
- Individuals that are not patients of the participating primary care practices
Contacts and Locations| United States, Pennsylvania | |
| University of Pittsburgh | |
| Pittsburgh, Pennsylvania, United States, 15213 | |
| Principal Investigator: | Trevor J Orchard, MD | University of Pittsburgh |
More Information
Additional Information:
Publications:
| Responsible Party: | Dr. Trevor Orchard, University of Pittsburgh |
| ClinicalTrials.gov Identifier: | NCT00480779 History of Changes |
| Other Study ID Numbers: | W81XWH-04-2-0030 |
| Study First Received: | May 29, 2007 |
| Last Updated: | June 9, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Pittsburgh:
|
Prediabetes Metabolic syndrome Prevention Lifestyle intervention |
Additional relevant MeSH terms:
|
Glucose Intolerance Prediabetic State Metabolic Syndrome X Hyperglycemia Glucose Metabolism Disorders |
Metabolic Diseases Diabetes Mellitus Endocrine System Diseases Insulin Resistance Hyperinsulinism |
ClinicalTrials.gov processed this record on May 19, 2013